Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125702291 | 12570229 | 1 | I | 20160330 | 20160719 | 20160719 | PER | US-MALLINCKRODT-T201601182 | MALLINCKRODT | 0.00 | M | Y | 102.00000 | KG | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125702291 | 12570229 | 1 | PS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 75 MCG/HR, Q 48 HRS | UNKNOWN | 77154 | TRANSDERMAL PATCH | ||||||||
| 125702291 | 12570229 | 2 | SS | Morphine | MORPHINE | 1 | Oral | 30 MG | Y | UNKNOWN | 0 | EXTENDED RELEASE TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125702291 | 12570229 | 1 | Pain |
| 125702291 | 12570229 | 2 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125702291 | 12570229 | Drug effect increased | |
| 125702291 | 12570229 | Drug ineffective | |
| 125702291 | 12570229 | Ear discomfort | |
| 125702291 | 12570229 | Headache | |
| 125702291 | 12570229 | Hyperhidrosis | |
| 125702291 | 12570229 | Product adhesion issue | |
| 125702291 | 12570229 | Weight decreased | |
| 125702291 | 12570229 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |